Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Susan A McDonald

Showing results (1-10 of 14) with videos related to

Pageof 2
Sort By:
Headache|April 20, 2005
Pilot study evaluating preference for 3-mg versus 6-mg subcutaneous sumatriptanStephen H Landy, Judy E McGinnis, Susan A McDonald
Headache|February 16, 2007
Clarification of developing and established clinical allodynia and pain-free outcomesStephen H Landy, Judy E McGinnis, Susan A McDonald
Therapeutic Advances in Neurological Disorders|December 24, 2010
Fixed-dose Sumatriptan/Naproxen Sodium Compared with each Monotherapy Utilizing the Novel Composite Endpoint of Sustained Pain-free/no Adverse EventsStephen Landy, Jonathan White, Shelly E Lener, et al.
Clinical Therapeutics|July 20, 2010
Pharmacokinetics and tolerability of sumatriptan after single-dose administration of a fixed-dose combination tablet of sumatriptan/naproxen sodium 85/500 mg followed two hours later by subcutaneous sumatriptan 4- or 6-mg injection: a randomized, open-label, three-period crossover study in healthy volunteersAlienor Berges, Christine Walls, Shelly E Lener, et al.
Headache|January 18, 2006
Gastric stasis in migraine: more than just a paroxysmal abnormality during a migraine attackSheena K Aurora, Shashidhar H Kori, Pat Barrodale, et al.
Headache|May 15, 2009
Revisiting the efficacy of sumatriptan therapy during the aura phase of migraineSheena K Aurora, Patricia M Barrodale, Susan A McDonald, et al.
Headache|February 6, 2010
Distinct pharmacokinetic profile and safety of a fixed-dose tablet of sumatriptan and naproxen sodium for the acute treatment of migraineLynda J Haberer, Christine M Walls, Shelly E Lener, et al.
Medgenmed : Medscape General Medicine|October 24, 2007
Two double-blind, multicenter, randomized, placebo-controlled, single-dose studies of sumatriptan/naproxen sodium in the acute treatment of migraine: function, productivity, and satisfaction outcomesStephen Landy, Sarah E DeRossett, Alan Rapoport, et al.
Epilepsy Research|April 15, 2014
Adjunctive use of ezogabine/retigabine with either traditional sodium channel blocking antiepileptic drugs (AEDs) or AEDs with other mechanisms of action: Evaluation of efficacy and tolerabilityMartin J Brodie, Jacqueline A French, Susan A McDonald, et al.
Journal of Women'S Health (2002)|March 4, 2014
Relief of menstrual symptoms and migraine with a single-tablet formulation of sumatriptan and naproxen sodiumVincent T Martin, Jeanne Ballard, Michael P Diamond, et al.
Pageof 2

Showing results (1-10 of 14) with videos related to

Sort By:
Pageof 2
Headache|April 20, 2005
Pilot study evaluating preference for 3-mg versus 6-mg subcutaneous sumatriptanStephen H Landy, Judy E McGinnis, Susan A McDonald
Headache|February 16, 2007
Clarification of developing and established clinical allodynia and pain-free outcomesStephen H Landy, Judy E McGinnis, Susan A McDonald
Therapeutic Advances in Neurological Disorders|December 24, 2010
Fixed-dose Sumatriptan/Naproxen Sodium Compared with each Monotherapy Utilizing the Novel Composite Endpoint of Sustained Pain-free/no Adverse EventsStephen Landy, Jonathan White, Shelly E Lener, et al.
Clinical Therapeutics|July 20, 2010
Pharmacokinetics and tolerability of sumatriptan after single-dose administration of a fixed-dose combination tablet of sumatriptan/naproxen sodium 85/500 mg followed two hours later by subcutaneous sumatriptan 4- or 6-mg injection: a randomized, open-label, three-period crossover study in healthy volunteersAlienor Berges, Christine Walls, Shelly E Lener, et al.
Headache|January 18, 2006
Gastric stasis in migraine: more than just a paroxysmal abnormality during a migraine attackSheena K Aurora, Shashidhar H Kori, Pat Barrodale, et al.
Headache|May 15, 2009
Revisiting the efficacy of sumatriptan therapy during the aura phase of migraineSheena K Aurora, Patricia M Barrodale, Susan A McDonald, et al.
Headache|February 6, 2010
Distinct pharmacokinetic profile and safety of a fixed-dose tablet of sumatriptan and naproxen sodium for the acute treatment of migraineLynda J Haberer, Christine M Walls, Shelly E Lener, et al.
Medgenmed : Medscape General Medicine|October 24, 2007
Two double-blind, multicenter, randomized, placebo-controlled, single-dose studies of sumatriptan/naproxen sodium in the acute treatment of migraine: function, productivity, and satisfaction outcomesStephen Landy, Sarah E DeRossett, Alan Rapoport, et al.
Epilepsy Research|April 15, 2014
Adjunctive use of ezogabine/retigabine with either traditional sodium channel blocking antiepileptic drugs (AEDs) or AEDs with other mechanisms of action: Evaluation of efficacy and tolerabilityMartin J Brodie, Jacqueline A French, Susan A McDonald, et al.
Journal of Women'S Health (2002)|March 4, 2014
Relief of menstrual symptoms and migraine with a single-tablet formulation of sumatriptan and naproxen sodiumVincent T Martin, Jeanne Ballard, Michael P Diamond, et al.
Pageof 2